Beckmann H, Haas S
Psychopharmacology (Berl). 1980;71(1):79-82. doi: 10.1007/BF00433257.
The pharmacological properties and the equivocal antipsychotic effects of diazepam reported in the literature suggested the use of high doses of this drug on schizophrenic patients to re-evaluate its usefulness. Treatment of 15 schizophrenic patients with doses of up to 400 mg/day showed a specific effect on hallucinations and certain forms of delusion. One group (nine patients with paranoid-hallucinatory and one with schizo-affective psychosis) showed a significant reduction in psychopathology as documented in the Brief Psychiatric Rating Scale (BPRS) and the Global Clinical Impressions (GCI), whereas five other patients (all of the schizo-affective type with symptoms of depression, euphoria, and/or psychotic anxiety) did not respond and had to be withdrawn from the study. Under the treatment an absence of sedative effects and a development of the feeling of well-being and euphoria were noticed. In three patients with doses of over 260 mg/day a marked loss of inhibitions in sexual and social behaviour was observed. It is concluded that high doses of diazepam may be useful in certain types of schizophrenia.
文献中报道的地西泮的药理特性及不确定的抗精神病作用表明,可对精神分裂症患者使用高剂量该药以重新评估其效用。对15例精神分裂症患者采用每日剂量高达400毫克的治疗显示,该药对幻觉及某些形式的妄想具有特效。一组患者(9例偏执幻觉型患者及1例精神分裂情感性精神病患者)在简明精神病评定量表(BPRS)及整体临床印象量表(GCI)中显示精神病理学有显著减轻,而另外5例患者(均为伴有抑郁、欣快及/或精神病性焦虑症状的精神分裂情感型患者)无反应,不得不退出研究。治疗过程中未观察到镇静作用,且出现了幸福感及欣快感。在3例每日剂量超过260毫克的患者中,观察到性及社交行为方面明显的抑制缺失。得出的结论是,高剂量地西泮可能对某些类型的精神分裂症有用。